- Home
- OLMA vs ABEO Comparison
OLMA vs ABEO Comparison
Compare OLMA & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- ABEO
- Stock Information
- Founded
- OLMA 2006
- ABEO 1974
- Country
- OLMA United States
- ABEO United States
- Employees
- OLMA N/A
- ABEO N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- OLMA Health Care
- ABEO Health Care
- Exchange
- OLMA Nasdaq
- ABEO Nasdaq
- Market Cap
- OLMA 299.7M
- ABEO 332.0M
- IPO Year
- OLMA 2020
- ABEO 1980
- Fundamental
- Price
- OLMA $5.76
- ABEO $7.23
- Analyst Decision
- OLMA Strong Buy
- ABEO Strong Buy
- Analyst Count
- OLMA 5
- ABEO 6
- Target Price
- OLMA $24.00
- ABEO $18.17
- AVG Volume (30 Days)
- OLMA 532.6K
- ABEO 730.2K
- Earning Date
- OLMA 08-11-2025
- ABEO 08-14-2025
- Dividend Yield
- OLMA N/A
- ABEO N/A
- EPS Growth
- OLMA N/A
- ABEO N/A
- EPS
- OLMA N/A
- ABEO 0.99
- Revenue
- OLMA N/A
- ABEO $400,000.00
- Revenue This Year
- OLMA N/A
- ABEO N/A
- Revenue Next Year
- OLMA N/A
- ABEO $339.63
- P/E Ratio
- OLMA N/A
- ABEO $7.31
- Revenue Growth
- OLMA N/A
- ABEO N/A
- 52 Week Low
- OLMA $2.86
- ABEO $3.93
- 52 Week High
- OLMA $13.93
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- OLMA 63.92
- ABEO 65.32
- Support Level
- OLMA $5.34
- ABEO $6.70
- Resistance Level
- OLMA $5.78
- ABEO $7.54
- Average True Range (ATR)
- OLMA 0.34
- ABEO 0.29
- MACD
- OLMA 0.05
- ABEO 0.05
- Stochastic Oscillator
- OLMA 85.90
- ABEO 78.32
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.